| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329507A Topical compositions comprising ascomycins |
| 01/02/2002 | CN1329506A Formulation with an improved therapeutic range, cntainng nucleotide synthesis inhibitors |
| 01/02/2002 | CN1329500A Anti-dandruff composition comprising antifungal polypeptide |
| 01/02/2002 | CN1328837A Medicine for curing alopecia and its preparation method |
| 01/02/2002 | CN1328833A Oil for curing burn, scald and sores |
| 01/02/2002 | CN1328821A Medicine for curing psoriasis |
| 01/02/2002 | CN1328815A Sunscreen compound containing basic component 4,4'-diarylbutadiene as uvioresistant light-filtering agent in cosmetics and medicine preparation |
| 01/01/2002 | US6335433 nrdD |
| 01/01/2002 | US6335427 Component of stem bromelain |
| 01/01/2002 | US6335368 Use of alverine for reducing wrinkles |
| 01/01/2002 | US6335359 Topically applying to skin or scalp to treat dermatitis or acne; side effect reduction |
| 01/01/2002 | US6335351 Antiulcer agents and antisecretory agents of gastric juice; gastrointestinal disorder and psoriasis treatment; adenosine triphosphatase inhibitors |
| 01/01/2002 | US6335342 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 01/01/2002 | US6335331 Antihistamines, antiallergens, brochodilator agents and antispasmodic agents |
| 01/01/2002 | US6335329 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/01/2002 | US6335320 Method of treating fibrotic conditions |
| 01/01/2002 | US6335312 Branched c10-18 alkyl endcapped ethylene oxide-propylene oxide polyethers terminated with a hydroxy group that is optionally sulfated |
| 01/01/2002 | US6335028 Implantable particles for urinary incontinence |
| 01/01/2002 | US6335023 Vehicles and oligosaccharide aldonic acids |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 01/01/2002 | CA2024156C Compositions for use in controling the shedding of hair and in the induction and stimulation of its growth, such compositions containing 2-amino pyrimidine 3-oxide derivatives andnovel 2-amino pyrimidine 3-oxide derivative compounds |
| 01/01/2002 | CA2020017C Novel composition and topical and systemic treatments of conditions caused by heavy, oily or greasy secretions |
| 12/29/2001 | CA2351904A1 Target |
| 12/29/2001 | CA2342059A1 Angiogenesis inhibitor |
| 12/27/2001 | WO2001098481A2 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | WO2001098362A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098348A2 Regulation of cellproliferation and differentiation using topically applied peptides |
| 12/27/2001 | WO2001098344A2 Angiogenesis-modulating compositions and uses |
| 12/27/2001 | WO2001098332A2 Secreted redox proteins |
| 12/27/2001 | WO2001098330A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 12/27/2001 | WO2001098325A1 Methods for treating and preventing alopecia |
| 12/27/2001 | WO2001098323A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098299A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | WO2001098289A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | WO2001098286A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098267A1 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001097864A1 The process of extracting from haw-pit by dry distillation and its device |
| 12/27/2001 | WO2001097850A2 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 12/27/2001 | WO2001097837A1 Solubilised protein vaccines |
| 12/27/2001 | WO2001097815A2 Use of glucocorticosteroids for producing a medicament to treat oligotrichia |
| 12/27/2001 | WO2001097795A2 Systems and methods for treating a mucosal surface |
| 12/27/2001 | WO2001097771A2 Preparations that contain an extract of the plant pistia stratiotes |
| 12/27/2001 | WO2001097770A1 Method for protecting human skin |
| 12/27/2001 | WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 12/27/2001 | WO2001062223A3 Cosmetic preparations containing plant extracts |
| 12/27/2001 | WO2001060349B1 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 12/27/2001 | WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity |
| 12/27/2001 | WO2001046256A3 Vesicle trafficking proteins |
| 12/27/2001 | WO2001045650A3 Cosmetic use of the residues from wine production |
| 12/27/2001 | WO2001039795A3 Attenuation of fibroblast proliferation |
| 12/27/2001 | WO2001037782A3 Method and composition for the treatment of scars |
| 12/27/2001 | WO2001021159A3 Pharmaceutical composition of nateglinide and another antidiabetcagent |
| 12/27/2001 | WO2000067626A3 Oat extracts: refining, compositions and methods of use |
| 12/27/2001 | WO2000055109A9 Lipoxin compounds and their use |
| 12/27/2001 | US20010056183 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056105 Useful as cosmetic for hair and body hygiene, and for treatment of dermatological complaints, with an inflammatory and/or immunoallergic component of rheumatic or respiratory type, cardivascular and opthalmogical disorders |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010056097 Therapeutic agent for dermatitis |
| 12/27/2001 | US20010055622 Antimicrobial bioabsorbable materials |
| 12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2413860A1 Regulation of cellproliferation and differentiation using topically applied peptides |
| 12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2412215A1 Angiogenesis-modulating compositions and uses |
| 12/27/2001 | CA2412188A1 3-azabicyclo¬3.1.0|hexane derivatives useful in therapy |
| 12/27/2001 | CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | CA2411865A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | CA2411585A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | CA2411236A1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | CA2410208A1 Systems and methods for treating a mucosal surface |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/26/2001 | CN1328545A Hydrazine derivatives |
| 12/26/2001 | CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors |
| 12/26/2001 | CN1328466A Use of antifungal agents for treating scleroses |
| 12/26/2001 | CN1327851A Caspule for dispelling wind and detoxicating body |
| 12/26/2001 | CN1327843A Exterior-applied liquid medicine for treating miliaria |
| 12/26/2001 | CN1327837A Exterior-applied liquid medicine for treating skin itching and its preparing process |
| 12/26/2001 | CN1327832A Exterior-applied ointment for treating dermatitis |
| 12/26/2001 | CN1327831A Chinese medicine for treating tinea and antipruritic |
| 12/26/2001 | CN1327829A Tea leaf-seed ointment for treating scald and its preparing process |
| 12/26/2001 | CN1327827A Exterior-applied medicine for treating dermatopathy |
| 12/26/2001 | CN1327822A Universal red Zn-base ointment for treating injury and its prparing process |
| 12/26/2001 | CN1327810A Exterior-applied medicine for treating dermatopathy |
| 12/26/2001 | CN1076618C Liquid medicine for treating wound and pain and preparing process thereof |
| 12/26/2001 | CN1076613C Medicine for treating burn and scald |
| 12/26/2001 | CN1076607C Process for preparing pharmaceutical composition containing novel steroid esters |